RK

Rohit Kasturi

Active Director Director DIN 05143969
DIN 05143969 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2011
Shareholding value •••• Premium profile

About Rohit Kasturi

Data last updated:

Rohit Kasturi is a Director at Pharma Corp. Inc. Private Limited (since 2011). The company operates in Pharma. Pharma Corp. Inc. Private Limited reported revenue of ₹48.87 Cr (FY 2025).

DIN 05143969
Primary Designation Director
Industry Pharma
First Appointment 10 Dec 2011
Oldest Company Age 17 yrs
Largest company Pharma Corp. Inc. Private Limited · ₹48.87 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharma Corp. Inc. Private Limited U24230MP2008PTC021361
Director10 Dec 20112008₹48.87 Cr (FY 2025)Active

Board colleagues of Rohit Kasturi

Directorship timeline

Open interactive timeline →
Pharma Corp. Inc. Private Limited
Premium access

Shareholding and investment profile for Rohit Kasturi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohit Kasturi

Rohit Kasturi currently holds 1 directorship: Pharma Corp. Inc. Private Limited (Director, since 10 Dec 2011, revenue ₹48.87 Cr (FY 2025)).

Rohit Kasturi was first appointed on 10 Dec 2011 as Director at Pharma Corp. Inc. Private Limited.

The current boards of Rohit Kasturi's companies include Neeraj Ghanani (Pharma Corp. Inc. Private Limited), Rajesh Kasturi (Pharma Corp. Inc. Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available